Literature DB >> 19440893

Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells.

E Kassi1, T G Sourlingas, M Spiliotaki, Z Papoutsi, H Pratsinis, N Aligiannis, P Moutsatsou.   

Abstract

In this report we determine the ability of ursolic acid (UA) to induce apoptosis and to modulate glucocorticoid receptor (GR) and Activator Protein-1 (AP-1) in MCF-7 cells. The UA-induced apoptosis (53 microM), the PARP cleavage, and the decrease in Bcl-2 protein (53 microM) support the notion that UA induces apoptosis through the intrinsic mitochondrial pathway. UA binds GR (relative binding affinity: 2.57) and translocates GR into nucleus, suggesting its potential as a GR modulator. UA had no effect on GRE- or TRE-driven gene expression. In summary, UA is a GR modulator and may be considered as a potential anticancer agent in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19440893     DOI: 10.1080/07357900802672712

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  43 in total

1.  Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory network.

Authors:  Anne Trécul; Franck Morceau; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2012-01-25       Impact factor: 5.523

2.  Identification of SR2211: a potent synthetic RORγ-selective modulator.

Authors:  Naresh Kumar; Brent Lyda; Mi Ra Chang; Janelle L Lauer; Laura A Solt; Thomas P Burris; Theodore M Kamenecka; Patrick R Griffin
Journal:  ACS Chem Biol       Date:  2012-02-13       Impact factor: 5.100

Review 3.  Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity.

Authors:  Thomas P Burris; Scott A Busby; Patrick R Griffin
Journal:  Chem Biol       Date:  2012-01-27

4.  Ursolic acid induces apoptosis in human leukaemia cells and exhibits anti-leukaemic activity in nude mice through the PKB pathway.

Authors:  Ning Gao; Senping Cheng; Amit Budhraja; Ziyi Gao; Jieping Chen; E-Hu Liu; Cheng Huang; Deying Chen; Zailin Yang; Qun Liu; Ping Li; Xianglin Shi; Zhuo Zhang
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

5.  Development and characterisation of ursolic acid nanocrystals without stabiliser having improved dissolution rate and in vitro anticancer activity.

Authors:  Ju Song; Yancai Wang; Yuelin Song; Hokman Chan; Chao Bi; Xiao Yang; Ru Yan; Yitao Wang; Ying Zheng
Journal:  AAPS PharmSciTech       Date:  2014-02       Impact factor: 3.246

6.  Anti-proliferative and pro-apoptotic effects of rosemary and constituent terpenoids in a model for the HER-2-enriched molecular subtype of clinical breast cancer.

Authors:  Nitin Telang
Journal:  Oncol Lett       Date:  2018-07-31       Impact factor: 2.967

Review 7.  Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer.

Authors:  Huanjie Yang; Q Ping Dou
Journal:  Curr Drug Targets       Date:  2010-06       Impact factor: 3.465

8.  Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists.

Authors:  Xiao Hu; Yahong Wang; Ling-Yang Hao; Xikui Liu; Chuck A Lesch; Brian M Sanchez; Jay M Wendling; Rodney W Morgan; Tom D Aicher; Laura L Carter; Peter L Toogood; Gary D Glick
Journal:  Nat Chem Biol       Date:  2015-01-05       Impact factor: 15.040

9.  Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and JNK.

Authors:  Sahdeo Prasad; Vivek R Yadav; Ramaswamy Kannappan; Bharat B Aggarwal
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

10.  Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine.

Authors:  Sahdeo Prasad; Vivek R Yadav; Bokyung Sung; Simone Reuter; Ramaswamy Kannappan; Amit Deorukhkar; Parmeswaran Diagaradjane; Caimiao Wei; Veerabhadran Baladandayuthapani; Sunil Krishnan; Sushovan Guha; Bharat B Aggarwal
Journal:  Clin Cancer Res       Date:  2012-07-25       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.